Duloxetine Eli Lilly
by
Anttila S, Leinonen E.
Department of Psychogeriatrics,
Tampere University Hospital, Pitkaniemi, Finland.
samia@koti.tpo.fi
Curr Opin Investig Drugs 2002 Aug;3(8):1217-21


ABSTRACT

Duloxetine is a serotonin (5-HT) and norepinephrine (NE) uptake inhibitor in pre-registration for depression. In vivo studies demonstrate that duloxetine inhibits 5-HT and NE transporters and this may induce an antidepressant effect [159168]. In humans, duloxetine has a low affinity for most 5-HT subtypes and for muscarinic, histamine H1, alpha1-adrenergic, alpha2-adrenergic and dopamine D2 receptors [444103]. Thus, it is not surprising that the meta-analysis of four recent clinical studies suggests duloxetine is a potent and well-tolerated antidepressant [429723]. By December 2001, Lilly had filed an NDA for depression. The launch of duloxetine is planned for the second half of 2002 [434250], [436220]. In April 2002, filing for stress urinary incontinence was anticipated for later in 2002 [456894]. Analysts at Banc of America predicted in April 2002, that the drug will be launched in the first quarter of 2003. The company projects US $400 million in revenue in 2003 and anticipates duloxetine to reach peak sales of over US $1 billion [450920]. Analysts at Morgan Stanley, projected US $25 million in sales in the fourth quarter 2002, rising to US $900 million in 2006 [450937]. At the same time, Credit Suisse First Boston anticipated launch for late 2002, with US $220 million in duloxetine revenues in 2003 and US $457 million in 2004 [450936].
Duloxetine (Cymbalta)
Duloxetine: hope or hype?
Duloxetine and depression
Duloxetine: a sceptical view
Duloxetine (Cymbalta): structure
Duloxetine for anxious depressives
Duloxetine: efficacy and tolerability
Duloxetine and urinary incontinence
Duloxetine (Cymbalta): pharmacology
Duloxetine for pain-ridden depressives
Duloxetine, serotonin and noradrenaline
New antidepressants : duloxetine (Cymbalta)
Dual-action antidepressants and slimming-drugs
Duloxetine, a balanced serotonin-noradrenaline reuptake inhibitor
Duloxetine (Cymbalta) for depressives with and without melancholia


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family